---
figid: PMC4444374__nihms652276f1a
figlink: /pmc/articles/PMC149053/figure/fig7/
number: F1a
caption: IL-10 signaling leads to the production of numerous gene products (indicated
  in red) that are capable of suppressing TLR- and IFNγ-signaling in a variety of
  ways. A. The binding of PAMPs to cell-surface (or intracellular) TLR initiates both
  MyD88-dependent and independent signaling cascades. Activation of the MyD88-dependent
  pathway leads to the activation of TRAF6 which in turn activates the MAPK pathway
  (p38, JNK and ERK MAP kinases), the PI3K/Akt pathway, and the NFκB pathway that
  lead to nuclear translocation of transcription factors and expression of TLR-stimulated
  genes. IL-10 signaling leads to STAT3-dependent transcription of miR146b, SOCS1/3,
  SHIP1, DUSP1, and AMP kinase that interfere with TLR signaling in various ways.
  miR-146b suppresses expression of TLR4, MyD88, IRAK1/4, and TRAF6 proteins while
  SOCS1, DUSP1, and SHIP1 suppress the activities of IRAK1/4, p38, and PI3K, respectively.
  AMP kinase interferes with NFκB signaling by inhibiting the degradation of the NFκB
  inhibitor IκB. SHIP1 also suppresses MyD88-independent TLR activation by suppressing
  TBK1 phosphorylation. IL-10 dependent expression of miR-187 and TTP can affect APC
  function by suppressing expression of inflammatory cytokines including TNF-α. B.
  The binding of IFNγ to IFNγ-receptor on monocytes/macrophages leads to STAT1-phosphorylation,
  nuclear translocation of active STAT1 homodimers, and STAT1 binding to gamma-activated
  sequences (GAS) on IFNγ-target genes. IL-10-signaling leads to the production of
  SOCS3 that suppresses Jak2-dependent activation of STAT1 in IFNγ-signaled APCs.
pmcid: PMC4444374
papertitle: Suppression of Antigen Presentation by IL-10.
reftext: Sharad K. Mittal, et al. Curr Opin Immunol. ;34:22-27.
pmc_ranked_result_index: '54675'
pathway_score: 0.9599301
filename: nihms652276f1a.jpg
figtitle: Suppression of Antigen Presentation by IL-10
year: ''
organisms:
- Homo sapiens
ndex: 9550fceb-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4444374__nihms652276f1a.html
  '@type': Dataset
  description: IL-10 signaling leads to the production of numerous gene products (indicated
    in red) that are capable of suppressing TLR- and IFNγ-signaling in a variety of
    ways. A. The binding of PAMPs to cell-surface (or intracellular) TLR initiates
    both MyD88-dependent and independent signaling cascades. Activation of the MyD88-dependent
    pathway leads to the activation of TRAF6 which in turn activates the MAPK pathway
    (p38, JNK and ERK MAP kinases), the PI3K/Akt pathway, and the NFκB pathway that
    lead to nuclear translocation of transcription factors and expression of TLR-stimulated
    genes. IL-10 signaling leads to STAT3-dependent transcription of miR146b, SOCS1/3,
    SHIP1, DUSP1, and AMP kinase that interfere with TLR signaling in various ways.
    miR-146b suppresses expression of TLR4, MyD88, IRAK1/4, and TRAF6 proteins while
    SOCS1, DUSP1, and SHIP1 suppress the activities of IRAK1/4, p38, and PI3K, respectively.
    AMP kinase interferes with NFκB signaling by inhibiting the degradation of the
    NFκB inhibitor IκB. SHIP1 also suppresses MyD88-independent TLR activation by
    suppressing TBK1 phosphorylation. IL-10 dependent expression of miR-187 and TTP
    can affect APC function by suppressing expression of inflammatory cytokines including
    TNF-α. B. The binding of IFNγ to IFNγ-receptor on monocytes/macrophages leads
    to STAT1-phosphorylation, nuclear translocation of active STAT1 homodimers, and
    STAT1 binding to gamma-activated sequences (GAS) on IFNγ-target genes. IL-10-signaling
    leads to the production of SOCS3 that suppresses Jak2-dependent activation of
    STAT1 in IFNγ-signaled APCs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOS
  - JUN
  - MAPK8
  - JUND
  - IRF3
  - IRF6
  - REL
  - RELA
  - MAPK14
  - MYD88
  - FOSL1
  - DUSP1
  - MAPK12
  - AKT2
  - AKT1
  - MFAP1
  - FOSL2
  - JUNB
  - FOSB
  - PIK3CB
  - MAPK1
  - MAPK3
  - AKT3
  - MAPK13
  - PIK3R6
  - TNF
  - PIK3R3
  - NFKB2
  - RELB
  - NFKB1
  - MAPK10
  - IRAK4
  - INPP5D
  - SOCS1
  - PIK3R4
  - PIK3CA
  - IRAK1
  - PIK3CG
  - MAPK11
  - TBK1
  - PIK3R5
  - TLR4
  - PIK3CD
  - MAPK9
  - Cancer
genes:
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: C-fos
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: DUSP1
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IRAK1/4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: SHIP
  symbol: SHIP
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5D
  entrez: '3635'
- word: Socs1
  symbol: SOCS1
  source: hgnc_symbol
  hgnc_symbol: SOCS1
  entrez: '8651'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IRAK1/4
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4444374__F1a
redirect_from: /figures/PMC4444374__F1a
figtype: Figure
---
